Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rank in Stocks
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Share Price
$8.03
Market Cap
$6.31B
Change (1 day)
1.07%
Change (1 year)
-8.04%
Country
CN
Trade Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Category
Healthcare
Dividend history for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Shenzhen New Industries Biomedical Engineering Co., Ltd. (stock symbol: 300832) made a total of 7 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $6.12
Dividend yield (TTM) : 0.0224
The sum of all dividends (adjusted for stock splits) is : $6.12
Dividend yield (TTM) : 0.0224
Dividend payments for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) from 2020 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | 14.00% |
| 2021 | $0.5263 | -33.34% |
| 2020 | $0.7895 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | -40.00% |
| 2021 | $1.00 | -33.33% |
| 2020 | $1.50 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 176.00% |
US
|
|
| 181.00% |
IE
|
|
| 87.00% |
US
|
|
| 0.00% |
US
|
|
| 8.00% |
DE
|
